NCT04964856

Brief Summary

A randomized, controlled, clinical trial on the efficacy of ERAS exercise improve perioperative frailty in patients undergoing elective laparoscopic colorectal surgery Objective to evaluate the efficacy of ERAS exercise improve perioperative frailty in patients undergoing elective laparoscopic colorectal surgery Participants: Patients undergoing elective laparoscopic colorectal surgery over 18 years old. The research intervention was ERAS exercise The study design was a randomized, parallel controlled trial ERAS exercise in perioperative period as the experimental group. No ERAS exercise group was the control group. The sample size was estimated according to the main efficacy index ( the attenuation of frailty after 7 days surgery) of this study. It was assumed that the attenuation of frailty in the ERAS exercise group was better than that of the control group. The parameters were set as test level (alpha) of 0.050 using a two-sided two-sample unequal-variance t-test, β = 0.9, according to the results of previous clinical trials and combined with literature, the population mean difference was 0.6 with standard deviations of 0.8 for the experimental group and 0.8 for the control group. the experimental group: the control group was 1:1, 39 cases in each group, considering the 20% shedding rate, 49 cases in the experimental group and 49 cases in the control group were selected.

  1. 1.The experimental group The patients take ERAS exercise from hospitalization to 30 days after operation.
  2. 2.The control group The patients do not take ERAS exercise in perioperative period.
  3. 3.The primary endpoint of the study was the attenuation of frailty via Frailty Phenotype (FP) between before surgery and 7days, 30 days after surgery.
  4. 4.Secondary endpoints included the 6-minute walk test (6MWT),nutritional risk screening (NRS2002), anxious and depressive states, activities of daily living (ADL),postoperative complications and mortality,short-term recovery quality,postoperative pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
98

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 16, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

July 16, 2021

Status Verified

July 1, 2021

Enrollment Period

7 months

First QC Date

March 19, 2021

Last Update Submit

July 14, 2021

Conditions

Keywords

ERASFrailtyExerciseActivity

Outcome Measures

Primary Outcomes (1)

  • Frailty status

    Frailty status (i.e. robust, prefrail or frail) measured using the Fried's Frailty Phenotype (FP) scores. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) and represent robust (0), pre-frail (1-2), and frail (3-5) health status.

    Change from Baseline Fried's Frailty Phenotype scores at 30 days postoperatively

Secondary Outcomes (10)

  • Change in gait speed

    baseline, at 30 days postoperatively

  • Handgrip strength

    baseline, at 30 days postoperatively

  • Perioperative functional capacity

    baseline, at 30 days postoperatively

  • Patient mood state

    baseline and 7th day postoperatively

  • Nutritional status

    baseline, at 30 days postoperatively

  • +5 more secondary outcomes

Study Arms (2)

ERAS exercise in perioperative period.

EXPERIMENTAL

The patients take ERAS exercise from hospitalization to 30 days after operation.

Behavioral: ERAS exercise

No ERAS exercise in perioperative period.

SHAM COMPARATOR

The patients do not take ERAS exercise in perioperative period.

Behavioral: No ERAS exercise

Interventions

ERAS exerciseBEHAVIORAL

Take ERAS exercise twice a day from hospitalization to 30 days after surgery

ERAS exercise in perioperative period.

Don't take ERAS exercise in perioperative period

No ERAS exercise in perioperative period.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients receiving elective laparoscopic colorectal surgery.
  • ≤age≤100 years old, no gender limit;
  • The ASA score is between I and Ⅲ;
  • Clearly understand and voluntarily participate in the study, and sign an informed consent form.

You may not qualify if:

  • Emergency surgery;
  • Those with a history of cognitive dysfunction;
  • Those with a history of neuromuscular diseases,;
  • American Society of Anesthesiologists class ⩾IV;
  • Those with a history of spontaneous pneumothorax, coagulation dysfunction,
  • Acute and systemic infectious diseases, moderate or higher fever;
  • Pregnant women;
  • History of drug abuse;
  • Those who judged by the physician in charge to be unsuitable for ERAS-exercise;
  • Other severe cardio-pulmonary diseases that would affect the 6MWD
  • Those failure to obtain informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400016, China

Location

Related Publications (1)

  • Yang F, Yuan Y, Liu W, Tang C, He F, Chen D, Xiong J, Huang G, Qian K. Effect of prehabilitation exercises on postoperative frailty in patients undergoing laparoscopic colorectal cancer surgery. Front Oncol. 2024 Sep 12;14:1411353. doi: 10.3389/fonc.2024.1411353. eCollection 2024.

MeSH Terms

Conditions

FrailtyMotor Activity

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University

Study Record Dates

First Submitted

March 19, 2021

First Posted

July 16, 2021

Study Start

May 1, 2021

Primary Completion

December 1, 2021

Study Completion

February 1, 2022

Last Updated

July 16, 2021

Record last verified: 2021-07

Locations